Authors: Strasser, JE Arnold, RL Pachuk, C Higgins, TJ Bernstein, DI

Citation: Je. Strasser et al., Herpes simplex virus DNA vaccine efficacy: Effect of glycoprotein D plasmid constructs, J INFEC DIS, 182(5), 2000, pp. 1304-1310

Authors: Higgins, TJ Herold, KM Arnold, RL McElhiney, SP Shroff, KE Pachuk, CJ

Citation: Tj. Higgins et al., Plasmid DNA-expressed secreted and nonsecreted forms of herpes simplex virus glycoprotein D2 induce different types of immune responses, J INFEC DIS, 182(5), 2000, pp. 1311-1320

Authors: Bernstein, DI Tepe, ER Mester, JC Arnold, RL Stanberry, LR Higgins, T

Citation: Di. Bernstein et al., Effects of DNA immunization formulated with bupivacaine in murine and guinea pig models of genital herpes simplex virus infection, VACCINE, 17(15-16), 1999, pp. 1964-1969

Authors: Sin, JI Kim, JJ Arnold, RL Shroff, KE McCallus, D Pachuk, C McElhiney, SP Wolf, MW Pompa-de Bruin, SJ Higgins, TJ Ciccarelli, RB Weiner, DB

Citation: Ji. Sin et al., IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4(+) T cell-mediated protective immunity against herpes simplex virus-2 challenge. (vol 162, pg 2912, 1999), J IMMUNOL, 163(2), 1999, pp. 1094-1094

Authors: Sin, JI Kim, JJ Arnold, RL Shroff, KE McCallus, D Pachuk, C McElhiney, SP Wolf, MW Pompa-de Bruin, SJ Higgins, TJ Ciccarelli, RB Weiner, DB

Citation: Ji. Sin et al., IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4(+) T cell-mediated protective immunity against herpes simplex virus-2 challenge, J IMMUNOL, 162(5), 1999, pp. 2912-2921